product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
RNA Polymerase II/POLR2A [p Ser2] Antibody
catalog :
NB100-1805
quantity :
0.1 ml
price :
499 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot, immunohistochemistry, immunoprecipitation, immunohistochemistry - paraffin section, proximity ligation assay
more info or order :
citations: 7
Reference
Zhang B, Li Y, Zhang J, Wang Y, Liang C, Lu T, et al. ADAR1 links R-loop homeostasis to ATR activation in replication stress response. Nucleic Acids Res. 2023;51:11668-11687 pubmed publisher
Igarashi T, Mazevet M, Yasuhara T, Yano K, Mochizuki A, Nishino M, et al. An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stress. Nat Commun. 2023;14:4991 pubmed publisher
Sch xfc tz M, Wangen C, Sommerer M, K xf6 gler M, Eickhoff J, Degenhart C, et al. Cytomegalovirus cyclin-dependent kinase ortholog vCDK/pUL97 undergoes regulatory interaction with human cyclin H and CDK7 to codetermine viral replication efficiency. Virus Res. 2023;335:199200 pubmed publisher
Brown R, Su X, Fair S, Wu K, Verra L, Jong R, et al. The RNA export and RNA decay complexes THO and TRAMP prevent transcription-replication conflicts, DNA breaks, and CAG repeat contractions. PLoS Biol. 2022;20:e3001940 pubmed publisher
Matos D, Zhang J, Ouyang J, Nguyen H, Genois M, Zou L. ATR Protects the Genome against R Loops through a MUS81-Triggered Feedback Loop. Mol Cell. 2020;77:514-527.e4 pubmed publisher
Tong Z, Mejía A, Veeranki O, Verma A, Correa A, Dokey R, et al. Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma. Ther Adv Med Oncol. 2019;11:1758835919864850 pubmed publisher
Tong Z, Chatterjee D, Deng D, Veeranki O, Mejía A, Ajani J, et al. Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma. Oncotarget. 2017;8:28696-28710 pubmed publisher
product information
master code :
NB100-1805
SKU :
NB100-1805
product name :
RNA Polymerase II/POLR2A [p Ser2] Antibody
unit size :
0.1 ml
description :
The RNA Polymerase II/POLR2A [p Ser2] Antibody from Novus is a rabbit polyclonal antibody to RNA Polymerase II/POLR2A. This antibody reacts with human,mouse,yeast. The RNA Polymerase II/POLR2A [p Ser2] Antibody has been validated for the following applications: Western Blot,Proximity Ligation Assay,Immunohistochemistry,Immunoprecipitation,Immunohistochemistry-Paraffin,Single Cell Western.
target :
RNA Polymerase II/POLR2A
category :
Primary Antibodies
buffer :
TBS and 0.1% BSA
clonality :
Polyclonal
concentration :
0.2 mg/ml
conjugate :
Unconjugated
host :
Rabbit
immunogen :
Immunogen for this antibody was a phosphorylated synthetic peptide, which represented a portion of human RNA Polymerase II (GeneID 5430) around serine 2 of the C-terminal repeat YSPTSPS.
isotype :
IgG
purity :
Immunogen affinity purified
species :
Human,Mouse,Yeast
specificity :
RNA Polymerase 2 Phosphospecific [Ser2]
gene symbol :
POLR2A
Antibody validation :
Biological Validation
accessionNumbers :
P24928
applications :
Western Blot,Proximity Ligation Assay,Immunohistochemistry,Immunoprecipitation,Immunohistochemistry-Paraffin,Single Cell Western
USD :
499 USD
alt names :
DNA-directed RNA polymerase II largest subunit, RNA polymerase II 220 kdsubunit, DNA-directed RNA polymerase II subunit A, DNA-directed RNA polymerase II subunit RPB1, DNA-directed RNA polymerase III largest subunit, EC 2.7.7.48, EC 2.7.7.6, hRPB220, hsRPB1, MGC75453, POLR2, POLRA, polymerase (RNA) II (DNA directed) polypeptide A (220kD), polymerase (RNA) II (DNA directed) polypeptide A, 220kDa, RNA Pol 2, RNA Polymerase 2, RNA polymerase II subunit B1, RNA-directed RNA polymerase II subunit RPB1, RNAPII, RPB1, RPBh1, RpIILS, RPO2, RPOL2
storage :
Store at 4C. Do not freeze.
more info or order :
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.